Evidence map›Paper›PMID 30980165›Full record

ReviewWiener klinische Wochenschrift2019

[Smoking, alcohol and diabetes (Update 2019)].

Helmut Brath, Susanne Kaser, Christian Tatschl, Peter Fasching

Abstract readReview
PubMed Publisher
In one paragraph

Review in Wiener klinische Wochenschrift, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Helmut BrathDiabetes- und Fettstoffwechselambulanz, Gesundheitszentrum Wien-Süd, Wienerbergstraße 13, 1100, Wien, Österreich. helmut.brath@wgkk.at.
Susanne KaserDepartment für Innere Medizin I, Medizinische Universität Innsbruck, Innsbruck, Österreich.
Christian TatschlThe Telic Nutshell. Gesundheitskommunikation mit Sinn e.U., Wien, Österreich.
Peter Fasching5. Medizinische Abteilung für Endokrinologie, Rheumatologie und Akutgeriatrie, Wilhelminenspital der Stadt Wien, Wien, Österreich.
Allergiezentrum Wien West · ATInnsbruck Medical University · ATWilhelminen Hospital · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Smoking and second-hand smoke strongly increase incidence of diabetes and probability for its complications. Smoking cessation can lead to weight gain and increased diabetes risk; however, it decreases cardiovascular and total mortality. A basal diagnostics (Fagerström Test, exhaled CO) is the basis for successful smoking cessation. Supporting medication include Varenicline, Nicotine Replacement Therapy and Bupropion. Socio-economic as well as psychological factors play an important role for smoking and smoking cessation.Moderate consumption of alcohol possibly decreases risk for diabetes and cardiovascular diseases. Selection bias and underreporting in studies maybe contribute to a too optimistic view. On the other hand, alcohol increases in a dose dependant fashion excess morbidity and disability adjusted life years, especially by cancer, liver diseases and infections.

Indexed as

Diabetes MellitusSmoking CessationAlcohol DrinkingBenzazepinesBupropionHumansNicotinePractice Guidelines as TopicQuinoxalinesSmokingTobacco Use Cessation DevicesVareniclineBenzazepinesBupropionNicotineQuinoxalinesVareniclineAlcoholDiabetes mellitusSecond Hand SmokeSmoking

Identifiers

PMID30980165
OpenAlexW2937262945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.